How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

MY

NASDAQ:MYNZ
Get a brief AI stock analysisSaves ~ 15 minutes of your time

MY

Mainz Biomed NVNASDAQ MYNZ Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is MYNZ undervalued compared to its fair value?

The fair value of MYNZ stock is hidden USD. Relative to the market price of 0.381 USD Mainz Biomed NV is hidden.

Mainz Biomed NV is a molecular genetics cancer diagnostic company. The company is headquartered in Mainz, Hessen and currently employs 27 full-time employees. The company went IPO on 2021-11-04. The firm operates under o...[More about valuation]

Mainz Biomed NV Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.008 $B

Price:

0.381 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.395

FINANCIALS

Mainz Biomed NV financial for reporting period

Income Statement

0.0002 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0056 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0063 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.0002 B 100%
0.0001 B 48%
-0.0056 B -3105%
-0.0063 B -3468%

Balance Sheet

0.018 B
0.0034 B

Financial Position Analysis

Assets

0.018 B
Current Assets
0.011 B
Total non-current assets
0.0069 B

Total current liabilities
0.011 B
Total non-current liabilities
0.0032 B

Cash Flow Statement

-0.0011 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0065 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Mainz Biomed NV fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is MYNZ attractive for investment based on fundamental analysis?

MYNZ stock rating is hidden. Mainz Biomed NV is a hidden by Eyestock methodology.

Get MYNZ Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

MYNZ analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for MYNZ to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Mainz Biomed NV competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Mainz Biomed NV dividends

MYNZ dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About MYNZ stock

About the company Mainz Biomed NV

Market cap $B

0.008

Dividend yield

Shares outstanding

12.010001 B

Mainz Biomed NV is a molecular genetics cancer diagnostic company. The company is headquartered in Mainz, Hessen and currently employs 27 full-time employees. The company went IPO on 2021-11-04. The firm operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The firm competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.

MYNZ profile

  • Ticker

    MYNZ

  • Country

    Germany

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    04 November 2021

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    27

  • City

    MAINZ

  • Address

    Sirius Gutenberg Park, Robert-Koch-Strasse 50

  • Cusip

    N5436L101